Elite in Malaria

Robert W. Sauerwein

Nijmegen, GE, NL 
Elite in Malaria
Nijmegen, GE, NL 
OverviewLocationsClinical Research

Overview

Robert Sauerwein practices in Nijmegen, Netherlands. Mr. Sauerwein is rated as an Elite expert by MediFind in the treatment of Malaria. His top areas of expertise are Malaria, Sepsis, Scarlet Fever, and Enlarged Liver.

His clinical research consists of co-authoring 237 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 200 articles and participated in 2 clinical trials in the study of Malaria.

Gender
Male

Locations

Nijmegen, GE, Netherlands
Other Locations
Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of Monoclonal Antibody TB31F in Healthy Malaria-naïve Adults in the Netherlands
Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of Monoclonal Antibody TB31F in Healthy Malaria-naïve Adults in the Netherlands
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Biological
Study Phase: Phase 1
Safety and Protective Efficacy of Genetically Attenuated Pf∆b9∆Slarp (PfSPZ-GA1) Malaria Parasites in Healthy Dutch Volunteers
Safety and Protective Efficacy of Genetically Attenuated Pf∆b9∆Slarp (PfSPZ-GA1) Malaria Parasites in Healthy Dutch Volunteers
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Biological, Other
Study Phase: Phase 1
View 1 Less Clinical Trial

237 Total Publications

Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats.
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats.
Journal: eLife
Published: January 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sauerwein's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile